Stock Market & Financial Investment News

News Breaks November 12, 2012 17:02 EDT SQNM Sequenom CMM's announces results of RetnaGene AMD Sequenom announced its wholly-owned subsidiary, Sequenom Center for Molecular Medicine, presented results from a study of its RetnaGene AMD laboratory-developed test to predict risk of disease progression during the 2012 Joint Meeting of the American Academy of Ophthalmology and the Asia-Pacific Academy of Ophthalmology in Chicago. This Sequenom CMM laboratory-developed genetic test combines patient disease stage with patient genetic variation to evaluate the risk of a patient with early or intermediate AMD to progress to advanced choroidal neovascularization, or CNV, disease within 2, 5, and 10 years. CNV is the most common form of 'wet' advanced age-related macular degeneration, or AMD, in which new blood vessels in the eye leak fluid, compromising central vision. Advanced disease impacts approximately 10% of AMD patients, but is associated with 90 percent of vision loss in AMD. News For SQNM From The Last 14 Days Check below for free stories on SQNM the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 13, 2013 10:09 EDT SQNM On The Fly: Analyst Upgrade Summary Subscribe for More Information 06:28 EDT SQNM Sequenom upgraded to Neutral from Underperform at Credit Suisse Subscribe for More Information May 10, 2013 12:31 EDT SQNM On The Fly: Midday Wrap Subscribe for More Information May 9, 2013 18:52 EDT SQNM On The Fly: After Hours Movers UP AFTER EARNINGS: Ubiquiti Networks (UBNT), up 11.6%... Unilife (UNIS), up 10.8%... Sequenom (SQNM), up 9.8%. DOWN AFTER EARNINGS: priceline.com (PCLN), down 3.2%... Allscripts (MDRX), down 6.1%... Air Lease (AL), down 10%. ALSO LOWER: Affymax (AFFY), down 11% after disclosing in a regulatory filing that its financial position may prevent it from continuing operations... Discovery Labs (DSCO), down 8.5% after filing to sell common stock... magicJack (CALL), down 6.4% after naming a new CFO. 16:24 EDT SQNM Sequenom reports Q1 EPS (26c), consensus (24c) Subscribe for More Information May 7, 2013 10:06 EDT SQNM Sequenom shares recommended at Maxim Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.